7th Annual RNA-Targeted Drug Discovery & Development Summit is sheduled on December 10-12, 2024 in Boston, USA.With Remix Therapeutics joining forces with Roche and Daiichi Sankyo partnering with Depixus, there has been many valuable collaborations entering the RNA-targeting field accelerating efficacious and selective small molecules targeting RNA directly, RNA-binding proteins and RNA/protein complexes.Hence, as the go-to meeting for the RNA-targeting small molecule the community, the 7th Annual RNA-Targeted Drug Discovery and Development Summit returns to Boston this December. Increase your knowledge of RNA tertiary structures, delve into innovative preclinical modelling strategies and identify optimal chemical features for advancing specific, efficacious and safe small molecules.

 [Read on rna-drugdiscovery.com](https://rna-drugdiscovery.com/take-part/register/)

The CPHI Middle East event, slated from December 10th to December 12th, 2024, in Riyadh, Saudi Arabia, is positioned to revolutionize the pharmaceutical industry landscape. It represents a crucial opportunity for industry professionals to capitalize on the Middle East and Africa's largest pharmaceutical market. With the Saudi Arabian pharmaceutical sector hitting USD 12.1 billion in 2023, attendees stand to tap into substantial growth prospects, establish vital connections with key stakeholders, and strategically position their brands for success. This event transcends mere networking, offering a platform for industry players to navigate and excel in the dynamic pharmaceutical market landscape of the region. 

[Read on cphi.com/middle-east](https://www.cphi.com/middle-east/en/home.html)

The Patient Recruitment for Rare Disease Trials Summit is held on 10-12 December 2024 in Boston, MA.In the face of unprecedented cost-per-patient expenses, the FDA's recent focus on rare disease, and a myriad of options for identifying, engaging, screening, and retaining eligible patients, it is essential to prioritize patient-centric recruitment strategies. As the landscape of rare disease research undergoes a transformative shift, by placing the patient at the heart of recruitment efforts, they can effectively address the significant unmet medical needs in rare diseases and streamline the pathway to innovative treatments.The Patient Recruitment for Rare Disease Trials Summit serves as the premier event for experts in patient recruitment, advocacy and clinical operations to unite in order to navigate cost-efficient, patient centric recruitment to expedite enrolment in rare disease trials. 

 [Read on patient-recruitment-rare-](https://patient-recruitment-rare-disease.com/take-part/register/)

2nd International Conference on Advances in Gastroenterology and Hepatology, set to take place in the vibrant city of Dubai, UAE, from December 11-12, 2024.The Gastroenterology 2024 will feature a diverse range of topics, including innovative treatments and techniques, precision medicine and personalized therapies for digestive diseases, the gut microbiome and its impact on digestive health and disease, advances in endoscopic techniques, including minimally invasive procedures and robotic-assisted surgery. New treatments for inflammatory bowel disease, such as biologics and small molecule therapies. These areas of focus have the potential to significantly improve patient care and outcomes. 

[Read on gastroconferences.org](https://gastroconferences.org/registration)

3rd Annual PAT & Real Time Quality Summit is held on 11 -12 December 2024 in Philadelphia, PA.With drug developers and manufacturers facing closer scrutiny on product quality than ever before, it's time to make the most of evolving process analytical technology (PAT) to design robust and cost-effective control strategies to understand more about your biopharmaceutical products.Recent blockbusters like GLP-1 peptides have sparked unprecedented investment into advanced manufacturing strategies, such as Novo Nordisk’s recent $11B acquisition to expand manufacturing capacity. The maturity of PAT tools and the development of sophisticated software and chemometrics now provide the perfect opportunity to revolutionize traditional quality and analytical approaches, achieving the digital manufacturing maturity necessary for the future. 


 [Read on rocess-analytical-technology](https://process-analytical-technology.com/take-part/register/)

Cell Therapy for Neurological Disorders Summit is held on 11-13 December 2024 in San Diego, California.As CAR-T and other cell therapies revolutionize cancer treatment, their potential for tackling neurological disorders like Alzheimer's, Parkinson's, ALS, and MS is sparking new excitement. These innovative therapies could dramatically change the treatment landscape, offering hope to millions of patients worldwide.The inaugural Cell Therapy for Neurological Disorders Summit is the first industry-focused event dedicated to exploring the latest advancements in cell therapies for neurological disorders. Join leading experts from companies like Aspen Neuroscience, Coya Therapeutics, and Neurona Therapeutics as they share cutting-edge developments in CAR-T, Treg, stem cell-based therapies, and more. 

[Read on cell-therapy-neurological.com](https://cell-therapy-neurological.com/register/)

The **World Congress on Clinical & Experimental Pediatric Ophthalmology** (Pediatric Ophthalmology 2024) is held on **December 11-12, 2024** in **Dubai, UAE.Pediatric Ophthalmology 2024** Offer the platform to learn about the latest diagnostic and therapeutic approaches, discuss challenging cases, and gain insights on best practices for treating pediatric eye disorders. The conference will feature keynote presentations, interactive panel discussions, and a variety of scientific sessions. This is an excellent opportunity for you to meet and connect with colleagues from around the world, exchange ideas and insights, and forge new collaborations.Networking is often cited as one of the most significant benefits of participating in the Pediatric Ophthalmology 2024. Take advantage of the many networking opportunities to visit with your colleagues, classmates, and friends. 

[Read on ophthalmologyconferences](https://ophthalmologyconferences.org/registration)

The 5th International Conference on Novel Functional Materials (ICNFM 2024) will be held during December 12-14, 2024 in Bangkok, Thailand. Following the traditions of previous successful ICNFM conferences held in Anshan, Shanghai, Xiamen, Hongkong, China, ICNFM 2024 will be served as a valuable platform to stimulate discussions on the cutting-edge research in novel functional materials. It will also provide opportunities for researchers, professionals, students, industry participants, entrepreneurs worldwide to share and discuss industrial development, research results and breakthrough innovations.

[Read on www.icnfm.net](https://www.icnfm.net/)

 ICRS Focus Meeting Patient Profiling & Juvenile Cartilage is held on 12 - 14 December 2024 Munich, Germany. A comprehensive ICRS Focus Meeting will address those questions, offer some answers, and help doctors, physiotherapists, sports scientists, a.o. to get better in cartilage repair and regeneration. Although much focus has been placed in recent years on the efficacy and efficiency of various techniques for treating cartilage damage in the knee joint, the indication and selection of patients is the most important parameter in cartilage regenerative therapy. This ICRS Focus Meeting focuses on clinical, imaging, and scientific aspects of this vital field and takes a look into the future to improve cartilage regenerative therapies further by knowing and influencing prognostic factors.  

[Read on cartilage.org](https://cartilage.org/icrs-patient-profiling/registration/)

The Genetics of Heart & Vascular Disease is held on 12-14 December 2024 in Puerto Rico,United States.During this 3 day CME course, experts in the field of genetic cardiology and cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of monogenetic, oligogenetic, and polygenic diseases affecting the heart and the blood vessels.Topics covered will include genetics and genomics 101, pharmacogenetics, polygenic risk scores, variant interpretation, the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, cardiac amyloid, and the aortopathies, the state of the molecular autopsy, and the state of gene therapy for CV diseases. 

[Read on cveducation.mayo.edu](https://cveducation.mayo.edu/store/genetics-of-heart-vascular-disease/pricing)